New business relationships start here
Evaluate the mechanism of action (MOA) of FDA-approved compounds in an artificial ebolavirus-specific minigenome containing the leader and trailer sequence of the ebolavirus genome and a CAT reporter gene in antisense orientation.
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
See attachment entitled Combined Synopsis and Soliciation
Julie Burns, 301-619-2189
US Army Medical Research Acquisition Activity
